Multiplicity of EGFR and KRAS Mutations in Non-small Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors | Anticancer Research
Overexpression of BZW1 and EGFR is a strong poor prognosis marker for... | Download Scientific Diagram
Overcoming therapy resistance in EGFR-mutant lung cancer | Nature Cancer
A favourable prognostic marker for EGFR mutant non-small cell lung cancer: immunohistochemical analysis of MUC5B | BMJ Open
Frontiers | EGFR-Dependent Extracellular Matrix Protein Interactions Might Light a Candle in Cell Behavior of Non-Small Cell Lung Cancer
Figures and data in Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer | eLife
IJMS | Free Full-Text | Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer
Value of serum tumor markers for predicting EGFR mutations and positive ALK expression in 1089 Chinese non-small-cell lung cancer patients: A retrospective analysis - ScienceDirect
Targeted therapies in lung cancer and Biomarkers
Frontiers | Rethink of EGFR in Cancer With Its Kinase Independent Function on Board
EGFR and Lung Cancer | American Lung Association
Cells | Free Full-Text | Emerging Molecular Dependencies of Mutant EGFR-Driven Non-Small Cell Lung Cancer
Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity - ScienceDirect
Classifying EGFR mutations by structure and function offers better way to match non-small cell lung cancer patients to treatments | MD Anderson Cancer Center
Lung cancer - The Lancet
Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-Small Cell Lung Cancer Associated With Poor Prognosis - eBioMedicine
Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer | BMC Cancer | Full Text
EGFR involved in tumorigenesis of non-small-cell lung cancer. Akt =... | Download Scientific Diagram
The biology of EGFR mutations in lung cancer. In normal cells, binding... | Download Scientific Diagram
Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non–small cell lung cancer | Science Immunology
Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop - ScienceDirect
EGFR | Cancer Genetics Web
Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes | Nature Communications
Molecular Markers and Targeted Therapies in the Management of Non-Small Cell Lung Cancer | MDedge Hematology and Oncology
